Jazz Pharmaceuticals (JAZZ)
| Company | Ticker | Sector | Industry | Quality | PAR |
|---|---|---|---|---|
| Jazz Pharmaceuticals | JAZZ | Healthcare | Biotechnology | 92 | 15.9% |
| Current Price (03/26) | $136.54 | |||
| CAPS Rating (Rate this stock on CAPS) |  |
|||
| Expected Income Statement | ||||
| Current Sales | 1,931.0 | |||
| Sales Growth Forecast | 13.6% | |||
| Net Profit Margin | 41.5% | |||
| Projected Shares Outstanding | 53.07 | |||
| EPS - Five year Forecast | $28.53 | |||
| Average P/E Ratio | 10.0 | |||
| Projected Average Price | $285.32 | |||
| Price Appreciation (Annualized) | 15.9% | |||
| Annual Dividend Yield | 0.0% | |||
| Projected Annual Return | 15.9% | |||
| Quality | ||||
| Financial Strength | 87 | 21.9 | ||
| EPS Stability | 87 | 21.8 | ||
| Industry Sales Growth Rate | 16.5% | 10.3 | ||
| Industry Net Profit Margin | 29.0% | 17.9 | ||
| Calculated Quality Rating | 71.8 | |||
| Fool CAPS | ||||
Total Players
308
Outperforms
68
Underperforms
All-Stars (72)
57
Outperforms (79%)
15
Underperforms
|
||||
| Fundamental Data Updated: 03/08/2019 | ||||